Cambridge, UK, 31 March 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces a significant expansion into a new ...

Immune cells (NK and cytotoxic T cells) are activated by short-synthetic mRNA which binds to the ZC3H12D receptor and is transported to the nucleus where it induces the expression of GZMB, a key ...

In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

The approval of messenger RNA (mRNA) based COVID-19 vaccines marked a pivotal scientific milestone, establishing mRNA as an innovative drug modality with immense therapeutic potential. However, due to ...

Scientists developed a groundbreaking class of mRNA medicines that can sense changes in the body and autonomously adjust their therapeutic effect. The new mRNA medicine works by responding to specific ...

Osaka, Japan — A research team from The University of Osaka and Institute of Science Tokyo has developed a groundbreaking class of mRNA medicines that can sense changes in the body and autonomously ...

Learn from the MHRA about evolving CMC expectations, submission criteria, and initiatives for streamlining approval routes for mRNA platforms. Continuous processing: Optimizing efficiency & ...

There's renewed debate on the future of mRNA vaccines, and Johns Hopkins researchers want to clear up some misconceptions around the shots. The mRNA vaccines gained attention during the height of ...